Eli Lilly LLY announced plans to acquire SiteOne Therapeutics to expand its pain pipeline. Moderna MRNA announced that the ...

The European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended the approval of ...

The Nifty 50 slipped 63 points, or 0.3%, to close at 24,752, while the Sensex shed 240 points, or 0.29%, ending at 81,312.

There’s already overlap in the pharmaceutical industry between the U.K. and Pennsylvania, but details in Trump’s trade deal with the island still need to be hashed out.

Boston Pharma is currently evaluating the ... stage development or under regulatory review. This year, GSK expects to launch five new products or line extensions. The FDA has already approved ...

Depemokimab reduces exacerbations regardless of baseline asthma control, suggesting uncontrolled symptoms are not necessary ...

A doctor and a patient discussing a therapy plan that includes pharmaceutical products. Formerly known as GlaxoSmithKline, GSK plc (NYSE:GSK) is a global biopharma company that develops and ...

In this article, we are going to take a look at where GSK plc (NYSE ... the United States imported around $203 billion in pharmaceutical products in 2023 alone. Around 73% of these imports came ...

GSK Pharma and Aditya Birla Capital shares too gained by around ... "However, it delivered a beat on EBITDA/PAT due to a superior product mix and controlled costs," it added. The shares of the company ...

The only shingles vaccine on the market in South Africa was discontinued last year. A newer and better vaccine is being used ...

GSK will acquire a liver-disease treatment from Boston Pharmaceuticals for up to $2 ... We sell different types of products and services to both investment professionals and individual investors.